GEODE CAPITAL MANAGEMENT, LLC - BIOXCEL THERAPEUTICS INC ownership

BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 85 filers reported holding BIOXCEL THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of BIOXCEL THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,070,629
-60.3%
423,120
+4.6%
0.00%
Q2 2023$2,694,969
-62.3%
404,650
+5.6%
0.00%
-100.0%
Q1 2023$7,149,187
+88665.7%
383,129
+2.2%
0.00%0.0%
Q4 2022$8,054
-99.8%
374,999
+5.5%
0.00%0.0%
Q3 2022$4,202,000
-7.4%
355,528
+3.4%
0.00%0.0%
Q2 2022$4,536,000
-30.4%
343,698
+10.3%
0.00%0.0%
Q1 2022$6,515,000
+6.4%
311,587
+3.4%
0.00%0.0%
Q4 2021$6,125,000
-32.1%
301,297
+1.4%
0.00%0.0%
Q3 2021$9,015,000
+12.1%
297,039
+7.3%
0.00%0.0%
Q2 2021$8,044,000
-26.2%
276,819
+9.6%
0.00%
-50.0%
Q1 2021$10,903,000
+5.3%
252,640
+12.7%
0.00%0.0%
Q4 2020$10,359,000
+15.9%
224,237
+8.8%
0.00%0.0%
Q3 2020$8,938,000
+4.5%
206,154
+27.7%
0.00%0.0%
Q2 2020$8,554,000
+182.3%
161,384
+19.0%
0.00%
+100.0%
Q1 2020$3,030,000
+30.9%
135,579
-14.4%
0.00%
Q4 2019$2,314,000
+432.0%
158,408
+155.9%
0.00%
Q3 2019$435,000
-34.3%
61,909
+2.4%
0.00%
Q2 2019$662,000
+164.8%
60,443
+138.5%
0.00%
Q1 2019$250,00025,3420.00%
Other shareholders
BIOXCEL THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 60,000$151,8000.16%
XTX Topco Ltd 33,605$85,0210.02%
Beacon Pointe Advisors, LLC 301,735$763,3900.01%
AllSquare Wealth Management LLC 4,527$11,4530.01%
Virtus ETF Advisers LLC 4,646$11,7540.01%
Y-Intercept (Hong Kong) Ltd 27,553$69,7090.01%
SeaCrest Wealth Management, LLC 16,550$41,8720.01%
Hennion & Walsh Asset Management, Inc. 33,940$85,8680.01%
Cutler Group LLC / CA 4,000$500.01%
Capital Investment Advisory Services, LLC 17,991$45,5170.00%
View complete list of BIOXCEL THERAPEUTICS INC shareholders